- Home
- RMBI vs VOR Comparison
RMBI vs VOR Comparison
Compare RMBI & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMBI
- VOR
- Stock Information
- Founded
- RMBI 1887
- VOR 2015
- Country
- RMBI United States
- VOR United States
- Employees
- RMBI N/A
- VOR N/A
- Industry
- RMBI Major Banks
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- RMBI Finance
- VOR Health Care
- Exchange
- RMBI Nasdaq
- VOR Nasdaq
- Market Cap
- RMBI 128.3M
- VOR 134.8M
- IPO Year
- RMBI 2019
- VOR 2021
- Fundamental
- Price
- RMBI $12.75
- VOR $0.62
- Analyst Decision
- RMBI
- VOR Strong Buy
- Analyst Count
- RMBI 0
- VOR 7
- Target Price
- RMBI N/A
- VOR $9.43
- AVG Volume (30 Days)
- RMBI 28.9K
- VOR 246.5K
- Earning Date
- RMBI 04-24-2025
- VOR 03-20-2025
- Dividend Yield
- RMBI 4.69%
- VOR N/A
- EPS Growth
- RMBI 1.10
- VOR N/A
- EPS
- RMBI 0.92
- VOR N/A
- Revenue
- RMBI $42,915,048.00
- VOR N/A
- Revenue This Year
- RMBI N/A
- VOR N/A
- Revenue Next Year
- RMBI N/A
- VOR N/A
- P/E Ratio
- RMBI $13.91
- VOR N/A
- Revenue Growth
- RMBI 2.81
- VOR N/A
- 52 Week Low
- RMBI $10.15
- VOR $0.62
- 52 Week High
- RMBI $15.15
- VOR $2.23
- Technical
- Relative Strength Index (RSI)
- RMBI 48.63
- VOR 23.92
- Support Level
- RMBI $12.60
- VOR $0.75
- Resistance Level
- RMBI $13.40
- VOR $0.93
- Average True Range (ATR)
- RMBI 0.38
- VOR 0.07
- MACD
- RMBI 0.08
- VOR -0.01
- Stochastic Oscillator
- RMBI 52.90
- VOR 0.00
About RMBI Richmond Mutual Bancorporation Inc.
Richmond Mutual Bancorp Inc is a United States-based banking company. Its principal business consists of attracting deposits from the general public & brokered deposits and investing those funds predominantly in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one-to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.